Results 161 to 170 of about 180,747 (217)
Some of the next articles are maybe not open access.

GLUCOSE‐6‐PHOSPHATE DEHYDROGENASE DEFICIENCY

British Journal of Haematology, 1970
It has long been recognized that certain ordinarily salutary drugs may produce an acute hemolytic anemia in some susceptible individuals. The 8-aminoquinoline antimalarial, pamaquine (plasmoquine), was such a medication. It was the investigation of the hemolytic effect of pamaquine and its derivatives which led to the recognition that hereditary red ...
Jane F. Desforges, Ernest Beutler
openaire   +3 more sources

Glucose-6-phosphate dehydrogenase deficiency

The Lancet, 2008
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human enzyme defect, being present in more than 400 million people worldwide. The global distribution of this disorder is remarkably similar to that of malaria, lending support to the so-called malaria protection hypothesis.
M.D. Cappellini, G. Fiorelli
openaire   +3 more sources

Glucose-6-phosphate dehydrogenase deficiency

Best Practice & Research Clinical Haematology, 2000
Glucose-6-phosphate dehydrogenase (G6PD) is expressed in all tissues, where it catalyses the first step in the pentose phosphate pathway. G6PD deficiency is prevalent throughout tropical and subtropical regions of the world because of the protection it affords during malaria infection.
A, Mehta, P J, Mason, T J, Vulliamy
openaire   +2 more sources

Glucose-6-phosphate dehydrogenase deficiency

Critical Reviews in Oncology/Hematology, 1995
Glucose-6-phosphate dehydrogenase (G6PD) is an X chromosome-linked enzyme and the key enzyme of the pentose phosphate pathway. The G6PD functions to reduce nicotinamide-adenine-dinucleotide phosphate (NADP) to a reduced form (NADPH), while it oxidizes glucosed-phosphate (G6P) in the hexose monophosphate shunt.
J G, Chang, T C, Liu
openaire   +2 more sources

Glucose-6-Phosphate Dehydrogenase Velletri

Acta Haematologica, 2009
A new variant of red cell glucose-6-phosphate dehydrogenase (G6PD) has been found in a Caucasian man with congenital non-spherocytic haemolytic anaemia. This variant has reduced activity, increased thermolability, increased Michaelis constants for glucose-6-phosphate and NADP, slightly increased electrophoretic mobility, and a biphasic pH-activity ...
F, Mandelli   +5 more
openaire   +2 more sources

Glucose-6-Phosphate Dehydrogenase

1985
Genetic systems have been of interest to human genetics mainly because they exhibit polymorphism in various populations, and therefore seem to be relevant to human evolution, or because they are associated with pathological manifestations. In addition, whereas frequently biological systems are easier to investigate in microorganisms or in experimental ...
L, Luzzatto, G, Battistuzzi
openaire   +2 more sources

Glucose 6-phosphate dehydrogenase and the kidney

Current Opinion in Nephrology and Hypertension, 2017
Glucose 6-phosphate dehydrogenase (G6PD) is the rate-limiting enzyme of the pentose phosphate pathway. G6PD is the main source of the essential cellular reductant, NADPH. The purpose of this review is to describe the biochemistry of G6PD and NADPH, cellular factors that regulate G6PD, normal physiologic roles of G6PD, and the pathogenic role altered ...
Netanya Y, Spencer, Robert C, Stanton
openaire   +2 more sources

Variants of Glucose 6-Phosphate Dehydrogenase

Annals of Internal Medicine, 1968
Excerpt Glucose 6-phosphate dehydrogenase (G6PD) is the enzyme that catalyzes the first step in the pentose phosphate shunt.
openaire   +2 more sources

Glucose-6-phosphate dehydrogenase deficiency

Baillière's Clinical Haematology, 1992
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human enzymopathy. Because its gene locus is on the X-chromosome it is more common in males than females in all populations. Prevalence rates vary from 62% among Kurdish Jews to the very low rates (0.1% or less in Japan, for example), which are compatible with sporadic cases arising
openaire   +2 more sources

Inhibition of glucose-6-phosphate dehydrogenase by steroids

Journal of Steroid Biochemistry, 1971
Abstract By incubation of purified human placental glucose-6-phosphate dehydrogenase (G-6-PDH) with DHA. its conjugates or other derivatives, it could be demonstrated that DHA sulfate, phosphate and glucuronoside do not inhibit this enzyme. Conversely, DHA sulfatide proved to be extremely active in the enzyme inhibition test, whereas lipophite DHA ...
P, Benes, G W, Oertel
openaire   +2 more sources

Home - About - Disclaimer - Privacy